NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered into ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount of ...
EL SEGUNDO, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (BYND) (the “Company” or “Beyond Meat”), a leader in plant-based meat, today announced the initial conversion rate for its 7.00% ...